Health economics of new and under-used vaccines in developing countries: state-of-the-art analyses for hepatitis B and rotavirus in Vietnam
PhD ceremony: Ms. T.H.A. Tu, 14.30 uur, Aula Academiegebouw, Broerstraat 5, Groningen
Dissertation: Health economics of new and under-used vaccines in developing countries: state-of-the-art analyses for hepatitis B and rotavirus in Vietnam
Promotor(s): prof. M.J. Postma
Faculty: Mathematics and Natural Sciences
Childhood vaccination in Vietnam is crucial for reducing infant mortality, concludes Hong Anh Thi Tu. Vietnam is a country, where universal childhood immunization has been successfully accomplished through the Expanded Programme on Immunization (EPI). Currently, nine routine childhood vaccines have been included into the EPI and in the future new vaccines will be added to the program. Vietnam has received substantial technical support from the World Health Organization (WHO) and financial support from international organizations such as the Global Alliance on Vaccines and Immunization (GAVI) for the EPI activities. Thus far, very few cost-effectiveness analyses or economic evaluations on childhood vaccination have been conducted in Vietnam despite the importance of health economic evaluations in assessing health care interventions.
Motivated by this, Tu decided to carry out cost-effectiveness analyses on hepatitis B and rotavirus vaccination, representing for under-used and new vaccines, respectively. The former is an existing vaccine in the EPI and the latter a newly recommended vaccine by the WHO. Her goal was to provide concrete health economic evidence to the government and to international organizations who commit to provide support to immunization in the developing world. In-depth and advanced analyses were carried out by her on hepatitis B and rotavirus vaccination.
Last modified: | 13 March 2020 12.59 a.m. |
More news
-
03 December 2024
ERC grants for three UG researchers
Researchers Bart Besselink, Else Starkenburg and Jagoda Slawinska have been awarded an ERC Consolidator Grant.
-
03 December 2024
Exploring the applications of CogniGron's revolutionary technology
In the second part of our series about the Groningen Cognitive Systems and Materials Center, we will explore the applications of its revolutionary technology and its potential social impact.
-
29 November 2024
Tuberculosis is back as the deadliest infectious disease
Read how University of Groningen scientists are fighting TB, the deadliest infectious disease of 2023.